Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

NCT00186251 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00186251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00186251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
March 31, 1998
Completion date
July 31, 2005
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease